| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 251.49 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 251.49. The average price that RMD shares were previous bought at was USD 244.86. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 37,464 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 86.8198 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 86.8198. The average price that LMAT shares were previous bought at was USD 88.5551. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in LMAT has increased by USD 3,602 compared to the previous valuation of LeMaitre Vascular Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| MASI - Masimo Corporation | HOLD | 0 @ USD 143.16 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 143.16. The average price that MASI shares were previous bought at was USD 154.973. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 4,366 compared to the previous valuation of Masimo Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 92.2 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 92.2. The average price that MDT shares were previous bought at was USD 89.4219. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 381,266 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 10.92 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 10.92. The average price that NVCR shares were previous bought at was USD 17.8097. The current market price is -38.7% lower than average price they were purchased at. The value of the holding in NVCR has fallen by USD 4,969 compared to the previous valuation of Novocure Ltd |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 19.45 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 19.45. The average price that NVST shares were previous bought at was USD 19.1276. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in NVST has fallen by USD 703 compared to the previous valuation of Envista Holdings Corp |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 14.9599 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 14.9599. The average price that OFIX shares were previous bought at was USD 15.4031. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in OFIX has increased by USD 1,438 compared to the previous valuation of Orthofix Medical Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 35.68 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 35.68. The average price that OMCL shares were previous bought at was USD 34.6291. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in OMCL has fallen by USD 517 compared to the previous valuation of Omnicell Inc |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 266.19 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 266.19. The average price that PEN shares were previous bought at was USD 259.067. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 8,537 compared to the previous valuation of Pennant International Group plc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 266.19 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 266.19. The average price that PEN shares were previous bought at was USD 259.067. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 8,537 compared to the previous valuation of PBF Energy Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 319.82 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 319.82. The average price that PODD shares were previous bought at was USD 293.253. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 35,120 compared to the previous valuation of Insulet Corporation |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 31.92 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 31.92. The average price that PRCT shares were previous bought at was USD 59.3385. The current market price is -46.2% lower than average price they were purchased at. The value of the holding in PRCT has increased by USD 4,779 compared to the previous valuation of Procept Biorobotics Corp however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 50.45 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 50.45. The average price that LIVN shares were previous bought at was USD 46.7757. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in LIVN has increased by USD 6,594 compared to the previous valuation of LivaNova PLC however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 15.77 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 15.77. The average price that SIBN shares were previous bought at was USD 15.3583. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in SIBN has increased by USD 2,951 compared to the previous valuation of Si-Bone Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| SRDX - SurModics Inc | HOLD | 0 @ USD 26.7903 | USD 0 | The current share valuation price of SRDX based on adjusted close was USD 26.7903. The average price that SRDX shares were previous bought at was USD 30.6595. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in SRDX has increased by USD 722 compared to the previous valuation of SurModics Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 263.77 | USD 0 | The current share valuation price of STE based on adjusted close was USD 263.77. The average price that STE shares were previous bought at was USD 229.731. The current market price is 14.8% higher than average price they were purchased at. The value of the holding in STE has increased by USD 50,812 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 356.03 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 356.03. The average price that SYK shares were previous bought at was USD 374.89. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in SYK has increased by USD 106,218 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 109.4 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 109.4. The average price that TFX shares were previous bought at was USD 142.319. The current market price is -23.1% lower than average price they were purchased at. The value of the holding in TFX has increased by USD 5,469 compared to the previous valuation of Teleflex Incorporated however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| TMCI - Treace Medical Concepts Inc | HOLD | 0 @ USD 4.46504 | USD 0 | The current share valuation price of TMCI based on adjusted close was USD 4.46504. The average price that TMCI shares were previous bought at was USD 7.60423. The current market price is -41.3% lower than average price they were purchased at. The value of the holding in TMCI has fallen by USD 10,627 compared to the previous valuation of Treace Medical Concepts Inc |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 119.17 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 119.17. The average price that TMDX shares were previous bought at was USD 93.1357. The current market price is 28.0% higher than average price they were purchased at. The value of the holding in TMDX has fallen by USD 27,545 compared to the previous valuation of TransMedics Group Inc |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 16.26 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 16.26. The average price that TNDM shares were previous bought at was USD 20.954. The current market price is -22.4% lower than average price they were purchased at. The value of the holding in TNDM has increased by USD 28,351 compared to the previous valuation of Tandem Diabetes Care Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 11.97 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 11.97. The average price that VREX shares were previous bought at was USD 11.354. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in VREX has increased by USD 443 compared to the previous valuation of Varex Imaging Corp however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 88.5 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 88.5. The average price that ZBH shares were previous bought at was USD 102.421. The current market price is -13.6% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 275 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 68.2599 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 68.2599. The average price that ITGR shares were previous bought at was USD 117.637. The current market price is -42.0% lower than average price they were purchased at. The value of the holding in ITGR has increased by USD 7,858 compared to the previous valuation of Integer Holdings Corp however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| AORT - Artivion Inc | HOLD | 0 @ USD 44.8701 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 44.8701. The average price that AORT shares were previous bought at was USD 34.7351. The current market price is 29.2% higher than average price they were purchased at. The value of the holding in AORT has fallen by USD 15,183 compared to the previous valuation of Artivion Inc |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 19.8 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 19.8. The average price that ATEC shares were previous bought at was USD 13.2192. The current market price is 49.8% higher than average price they were purchased at. The value of the holding in ATEC has increased by USD 4,596 compared to the previous valuation of Alphatec Holdings Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 32.05 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 32.05. The average price that ATRC shares were previous bought at was USD 35.4391. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in ATRC has increased by USD 3,793 compared to the previous valuation of AtriCure Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| AXGN - Axogen Inc | HOLD | 0 @ USD 23.57 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 23.57. The average price that AXGN shares were previous bought at was USD 16.3377. The current market price is 44.3% higher than average price they were purchased at. The value of the holding in AXGN has fallen by USD 2,521 compared to the previous valuation of Axogen Inc |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18. The average price that BAX shares were previous bought at was USD 27.4613. The current market price is -34.5% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 1,426 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 177.84 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 177.84. The average price that BDX shares were previous bought at was USD 201.977. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 17,934 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 100.02 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.02. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 199,867 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 100.02 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.02. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 199,867 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 43.97 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 43.97. The average price that CNMD shares were previous bought at was USD 56.641. The current market price is -22.4% lower than average price they were purchased at. The value of the holding in CNMD has fallen by USD 1,023 compared to the previous valuation of CONMED Corporation |
| DXCM - DexCom Inc | HOLD | 0 @ USD 55 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 55. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -26.8% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 164,653 compared to the previous valuation of DexCom Inc |
| ENOV - Enovis Corp | HOLD | 0 @ USD 28.06 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 28.06. The average price that ENOV shares were previous bought at was USD 36.4594. The current market price is -23.0% lower than average price they were purchased at. The value of the holding in ENOV has fallen by USD 2,901 compared to the previous valuation of Enovis Corp |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 83.39 | USD 0 | The current share valuation price of EW based on adjusted close was USD 83.39. The average price that EW shares were previous bought at was USD 73.2429. The current market price is 13.9% higher than average price they were purchased at. The value of the holding in EW has increased by USD 77,655 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 73.05 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 73.05. The average price that GEHC shares were previous bought at was USD 74.9346. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in GEHC has fallen by USD 71,102 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 83.86 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 83.86. The average price that GKOS shares were previous bought at was USD 106.937. The current market price is -21.6% lower than average price they were purchased at. The value of the holding in GKOS has increased by USD 16,446 compared to the previous valuation of Glaukos Corp however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| GMED - Globus Medical | HOLD | 0 @ USD 83.89 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 83.89. The average price that GMED shares were previous bought at was USD 70.2905. The current market price is 19.3% higher than average price they were purchased at. The value of the holding in GMED has increased by USD 349,024 compared to the previous valuation of Globus Medical however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.1 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.1. The average price that HOLX shares were previous bought at was USD 67.0007. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 1,549 compared to the previous valuation of Hologic Inc |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 12.04 | USD 0 | The current share valuation price of IART based on adjusted close was USD 12.04. The average price that IART shares were previous bought at was USD 17.8768. The current market price is -32.7% lower than average price they were purchased at. The value of the holding in IART has increased by USD 7,605 compared to the previous valuation of Integra LifeSciences Holdings however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 708.45 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 708.45. The average price that IDXX shares were previous bought at was USD 508.266. The current market price is 39.4% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 58,846 compared to the previous valuation of IDEXX Laboratories Inc |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 81.7899 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 81.7899. The average price that INSP shares were previous bought at was USD 135.25. The current market price is -39.5% lower than average price they were purchased at. The value of the holding in INSP has fallen by USD 7,557 compared to the previous valuation of Inspirit Energy Holdings Plc |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 174.6 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 174.6. The average price that IRTC shares were previous bought at was USD 129.4. The current market price is 34.9% higher than average price they were purchased at. The value of the holding in IRTC has fallen by USD 12,544 compared to the previous valuation of iRhythm Technologies Inc |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 560 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 560. The average price that ISRG shares were previous bought at was USD 509.787. The current market price is 9.8% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 609,106 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 126.36 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 126.36. The average price that ABT shares were previous bought at was USD 128.636. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in ABT has increased by USD 341,243 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-11-07 this would crystalise an overall loss. |
| QDEL - Quidel Corporation | SELL | -154 @ USD 20.35 | USD -3,134 | The ETF sold 154 shares of QDEL on 2025-11-07. The shares were previously bought for an average price of USD 34.337. The Quidel Corporation shares were sold for -40.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,154 The average price that the ETF previously sold QDEL share for is USD 35.2511 which is higher than the selling price of USD 20.35 on 2025-11-07. |